Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of Future (OTCMKTS:FRNWF) in a report released on Tuesday, The Fly reports.
Separately, Peel Hunt lowered shares of Future to a buy rating in a research note on Tuesday.
Get Future alerts:
FRNWF opened at $49.04 on Tuesday. Future has a fifty-two week low of $49.04 and a fifty-two week high of $49.04. The stock’s 50-day simple moving average is $35.37.
About Future
Future plc, together with its subsidiaries, publishes content for technology, games, TV and entertainment, women's lifestyle, real life, music, creative and photography, sports, home interest, and B2B sectors primarily in the United States and the United Kingdom. It operates through Media and Magazine segments.
Hot Bank Stocks To Buy Right Now: Foamix Pharmaceuticals Ltd.(FOMX)
Our legal and commercial name is Foamix Pharmaceuticals Ltd. (formerly Foamix Ltd.). We were incorporated as a limited liability company under the laws of the State of Israel on January 19, 2003. We are registered with the Israeli Registrar of Companies. Our registration number is 51-336881-1. Article 3 of our articles of association provides that our objectives are to conduct all types of business as are permitted by law. Our principal executive offices are located at 2 Holzman St., Weizmann Science Park, Rehovot 76704, Israel, and our telephone number is +972-8-9316233. Our website is www.foamixpharma.com. The information contained on, or that can be accessed through, our website does not constitute a part of this form and is not incorporated by reference herein. Foamix Pharmaceuticals Inc., our wholly-owned subsidiary, was incorporated on May 6, 2014 under the laws of the State of Delaware, with the intent to serve as our marketing and sales arm in the U.S. Advisors’ Opinion:
- [By Max Byerly]
HC Wainwright set a $11.00 price target on Foamix Pharmaceuticals (NASDAQ:FOMX) in a research note released on Tuesday. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.
- [By Joseph Griffin]
Foamix Pharmaceuticals (NASDAQ:FOMX)’s stock had its “buy” rating reiterated by HC Wainwright in a report issued on Wednesday, MarketBeat reports. They currently have a $14.00 price objective on the specialty pharmaceutical company’s stock, up from their prior price objective of $12.00. HC Wainwright’s price objective would indicate a potential upside of 122.22% from the stock’s current price.
- [By Chris Lange]
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
Hot Bank Stocks To Buy Right Now: GAIN Capital Holdings, Inc.(GCAP)
GAIN Capital Holdings, Inc. provides trading services and solutions to retail and institutional customers worldwide. The company operates in three segments: Retail, Institutional, and Futures. It specializes in over-the-counter (OTC) and exchange-traded markets. The company offers access to a range of financial products, including spot foreign exchange (forex), precious metals trading, and contracts for differences (CFD) on currencies, commodities, indices, individual equities, bonds, and interest rate products; and spread bets and OTC options on forex, as well as supports the trading of exchange-traded futures and options. It offers services to retail customers through FOREX.com and Cityindex.com, as well as through introducing brokers and white label partners. The company also provides agency execution services; and access to markets and self-directed trading in foreign exchange, commodities, equities, options, and futures to institutional customers through an electronic communications network, as well as offers touch services. In addition, it operates GTX platform, an electronic communications network that provides liquidity in spot and forward foreign exchange and precious metals to buy-side and sell-side firms, including banks, brokers, hedge funds, commodity trading advisors, and asset managers. Further, the company provides execution and risk management services for exchange-traded futures and futures options on U.S. and European futures and options exchanges. As of December 31, 2015, it had 173,738 funded retail accounts. GAIN Capital Holdings, Inc. was founded in 1999 and is headquartered in Bedminster, New Jersey.
